Atripla Side Effects

Experienced Counsel for Your HIV Drug Injury Claim

Atripla is the brand name for a drug developed by Gilead Sciences, Inc., which contains 3 different chemical compounds: tenofovir disoproxil fumarate (TDF), efavirenz (EFV), and embtricitabine (FTC). Together, these compounds act to treat HIV-1, and prevent HIV-positive patients from succumbing to AIDS.

While it was praised by many as a life-saving drug, Atripla has actually caused many individuals to experience unnecessary pain and suffering. From chronic kidney disease to tooth loss, this antiretroviral HIV treatment has caused severe, long-term injuries in many patients. Some studies have even shown that the drug decreases bone density in both animals and humans, and those who take Atripla in the long term may face severe injury risks.

Our HIV drug injury lawyers at Robert Peirce & Associates, P.C. have the means and the skill to fight back against corporate negligence at Gilead. With dedication and persistence, our attorneys can apply over 40 years of experience and a deep understanding ofprescription drug claims to your case – and seek to maximize your outcome.

Consult with our Pittsburgh defective drug attorneys today when you call (844) 383-0565 for a consultation.

What Are the Side Effects of Atripla?

Once the Food and Drug Administration (FDA) approved Atripla for public consumption in 2006, it quickly became one of the most popular treatments prescribed for HIV patients. As a daily treatment regimen, the three active ingredients in this medication offer potent protection against HIV cell replication. Unfortunately, they also make this drug unreasonably dangerous for consumers.

The most common side effects of Atripla include:

  • Upper respiratory tract infections
  • Osteoporosis
  • Severe rashes
  • Anxiety disorders
  • Kidney and renal system failure
  • Blisters and open wounds
  • Depression
  • Vomiting and diarrhea
  • Bone injuries
  • Tooth decay and tooth loss
  • Anemia

Holding Gilead Accountable for Defective Design

For over a decade, Atripla and other TDF-based medications were the only options available to most HIV patients – and in order for the treatment to be effective, patients were required to take high daily doses. Even though Gilead Sciences Inc. knew that this was the case – and that patients could be at risk of life-threatening bone and kidney disorders – the company kept a safer version of the same drug in development for over 10 years.

In the class action lawsuits that followed, many attorneys have alleged that Gilead intentionally withheld further information about Atripla in the hope of maximizing their profits. Furthermore, the company failed to develop their less-toxic version of the drug in a timely manner, in spite of the fact that it could have saved lives.

If you believe that you or your loved one’s injuries were caused by Atripla, you’re not alone in this fight. Our experienced legal team at Robert Peirce & Associates, P.C. will investigate you case and help you understand all the options available for fair compensation. Gilead should be held accountable for corporate negligence, and when you turn to our team, you may be able to find peace of mind for you and your family.

Schedule your free initial consultation online today. We serve clients throughout Pittsburgh, and we’re available 24/7 for inquiries.

Client Testimonials

  • My claims are being handled in a very efficient way.

    Paul

  • We have never felt more relaxed in a meeting!

    Maurine

  • We are so blessed to have had you represent us!

    Mike & Teresa

  • Thank you for all of your help!

    Jim & Carol

  • I will most definitely recommend highly

    Angel

  • Thank you! You girls are great!

    Joyce

Prev Next

Get Your Fair Chance at Maximum Recovery.

    • Please enter your name.
    • This isn't a valid phone number.
      Please enter your phone number.
    • This isn't a valid email address.
      Please enter your email address.
    • Please make a selection.
    • Please enter a message.
Put Us On Your Side